O	0	3	ERK	ERK	NN	B-NP
O	4	13	signaling	signaling	NN	I-NP
O	14	16	is	be	VBZ	B-VP
O	17	25	involved	involve	VBN	I-VP
O	26	28	in	in	IN	B-PP
O	29	39	decreasing	decrease	VBG	B-VP
O	40	44	BDNF	BDNF	NN	B-NP
O	44	45	-	-	HYPH	B-NP
O	45	52	induced	induce	VBN	I-NP
O	53	57	gene	gene	NN	I-NP
O	58	66	activity	activity	NN	I-NP
O	67	70	via	via	IN	B-PP
O	71	74	Eph	Eph	NNP	B-NP
O	75	84	receptors	receptor	NNS	I-NP

O	85	89	Data	Datum	NNS	B-NP
O	90	98	provided	provide	VBN	B-VP
O	99	101	so	so	RB	B-ADVP
O	102	105	far	far	RB	I-ADVP
O	106	113	suggest	suggest	VBP	B-VP
O	114	118	that	that	IN	B-SBAR
O	119	125	ephrin	ephrin	NN	B-NP
O	125	126	-	-	HYPH	B-NP
O	126	128	A5	A5	NN	I-NP
O	129	134	might	might	MD	B-VP
O	135	145	counteract	counteract	VB	I-VP
O	146	150	BDNF	BDNF	NN	B-NP
O	150	151	-	-	HYPH	B-NP
O	151	159	mediated	mediate	VBN	I-NP
O	160	164	gene	gene	NN	I-NP
O	165	175	expression	expression	NN	I-NP
O	176	179	and	and	CC	O
B-Cellular_component	180	186	growth	growth	NN	B-NP
I-Cellular_component	187	191	cone	cone	NN	I-NP
O	192	201	responses	response	NNS	I-NP
O	202	205	via	via	IN	B-PP
O	206	216	decreasing	decrease	VBG	B-VP
O	217	220	ERK	ERK	NN	B-NP
O	221	229	activity	activity	NN	I-NP
O	230	233	and	and	CC	O
B-Cellular_component	234	241	nuclear	nuclear	JJ	B-NP
O	242	254	localization	localization	NN	I-NP
O	255	256	(	(	(	O
O	256	260	Figs	Fig	NNS	B-NP
O	260	261	.	.	.	O
O	262	263	2	2	CD	B-NP
O	264	267	and	and	CC	I-NP
O	268	269	3	3	CD	I-NP
O	269	270	)	)	)	O
O	270	271	.	.	.	O

O	272	274	To	To	TO	B-VP
O	275	279	test	test	VB	I-VP
O	280	284	this	this	DT	B-NP
O	285	295	hypothesis	hypothesis	NN	I-NP
O	296	300	more	more	RBR	B-ADVP
O	301	309	directly	directly	RB	I-ADVP
O	309	310	,	,	,	O
O	311	313	we	we	PRP	B-NP
O	314	322	analyzed	analyze	VBD	B-VP
O	323	330	whether	whether	IN	B-SBAR
O	331	334	Eph	Eph	NNP	B-NP
O	335	342	forward	forward	JJ	I-NP
O	343	352	signaling	signaling	NN	I-NP
O	353	356	can	can	MD	B-VP
O	357	362	still	still	RB	I-VP
O	363	371	suppress	suppress	VB	I-VP
O	372	376	BDNF	BDNF	NN	B-NP
O	376	377	-	-	HYPH	O
O	377	387	stimulated	stimulate	VBN	B-NP
O	388	391	IEG	IEG	NN	I-NP
O	392	401	induction	induction	NN	I-NP
O	402	405	and	and	CC	O
B-Cellular_component	406	412	growth	growth	NN	B-NP
I-Cellular_component	413	417	cone	cone	NN	I-NP
O	418	426	collapse	collapse	NN	I-NP
O	427	431	when	when	WRB	B-ADVP
O	432	435	ERK	ERK	NN	B-NP
O	436	442	kinase	kinase	NN	I-NP
O	443	451	activity	activity	NN	I-NP
O	452	455	was	be	VBD	B-VP
O	456	470	experimentally	experimentally	RB	I-VP
O	471	477	raised	raise	VBN	I-VP
O	477	478	.	.	.	O

O	479	482	For	For	IN	B-PP
O	483	487	this	this	DT	B-NP
O	487	488	,	,	,	O
O	489	492	ERK	ERK	NN	B-NP
O	493	501	activity	activity	NN	I-NP
O	502	505	was	be	VBD	B-VP
O	506	514	elevated	elevate	VBN	I-VP
O	515	517	by	by	IN	B-PP
O	518	528	expressing	express	VBG	B-VP
O	529	543	constitutively	constitutively	RB	B-ADVP
O	543	544	-	-	HYPH	B-NP
O	544	550	active	active	JJ	I-NP
O	551	555	MEK1	MEK1	NN	I-NP
O	556	557	(	(	(	O
O	557	559	CA	CA	NN	B-NP
O	559	560	-	-	HYPH	B-NP
O	560	564	MEK1	MEK1	NN	I-NP
O	564	565	)	)	)	O
O	565	566	,	,	,	O
O	567	569	an	an	DT	B-NP
O	570	573	ERK	ERK	NN	I-NP
O	574	582	upstream	upstream	JJ	I-NP
O	583	592	activator	activator	NN	I-NP
O	592	593	,	,	,	O
O	594	596	in	in	IN	B-PP
B-Cell	597	605	cortical	cortical	JJ	B-NP
I-Cell	606	613	neurons	neuron	NNS	I-NP
O	614	615	(	(	(	O
O	615	618	Fig	Fig	NNP	B-NP
O	618	619	.	.	.	O
O	620	622	S3	S3	''	O
O	622	623	)	)	)	O
O	623	624	.	.	.	O

O	625	637	Subsequently	Subsequently	RB	B-ADVP
O	637	638	,	,	,	O
B-Cell	639	646	neurons	neuron	NNS	B-NP
O	647	651	were	be	VBD	B-VP
O	652	661	subjected	subject	VBN	I-VP
O	662	664	to	to	TO	B-PP
O	665	671	either	either	CC	O
O	672	674	an	an	DT	B-NP
O	675	681	ephrin	ephrin	NN	I-NP
O	681	682	-	-	HYPH	I-NP
O	682	684	A5	A5	NN	I-NP
O	685	693	mediated	mediate	VBN	I-NP
B-Cellular_component	694	700	growth	growth	NN	I-NP
I-Cellular_component	701	705	cone	cone	NN	I-NP
O	706	714	collapse	collapse	NN	I-NP
O	715	720	assay	assay	NN	I-NP
O	721	722	(	(	(	O
O	722	725	Fig	Fig	NNP	B-NP
O	725	726	.	.	.	I-NP
O	727	728	5	5	CD	I-NP
O	728	729	)	)	)	O
O	730	732	or	or	CC	O
O	733	743	stimulated	stimulate	VBN	B-VP
O	744	748	with	with	IN	B-PP
O	749	757	guidance	guidance	NN	B-NP
O	758	762	cues	cue	NNS	I-NP
O	763	766	for	for	IN	B-PP
O	767	769	20	20	CD	B-NP
O	770	777	minutes	minute	NNS	I-NP
O	778	781	and	and	CC	O
O	782	785	IEG	IEG	NN	B-NP
O	786	790	mRNA	mRNA	NN	I-NP
O	791	797	levels	level	NNS	I-NP
O	798	802	were	be	VBD	B-VP
O	803	813	quantified	quantify	VBN	I-VP
O	814	817	via	via	IN	B-PP
O	818	821	qRT	qRT	NN	B-NP
O	821	822	-	-	HYPH	B-NP
O	822	825	PCR	PCR	NN	I-NP
O	826	827	(	(	(	O
O	827	830	Fig	Fig	NNP	B-NP
O	830	831	.	.	.	I-NP
O	832	833	6	6	CD	I-NP
O	833	834	)	)	)	O
O	834	835	.	.	.	O

O	836	838	10	10	CD	B-NP
O	838	839	.	.	.	I-NP
O	839	843	1371	1371	CD	I-NP
O	843	844	/	/	SYM	I-NP
O	844	851	journal	journal	NN	I-NP
O	851	852	.	.	SYM	I-NP
O	852	856	pone	pone	NN	I-NP
O	856	857	.	.	.	O
O	857	864	0026089	0026089	CD	B-NP
O	864	865	.	.	.	O
O	865	869	g005	g005	CD	B-NP
O	870	876	Figure	Figure	NNP	I-NP
O	877	878	5	5	CD	I-NP

O	879	893	Constitutively	Constitutively	RB	B-NP
O	893	894	-	-	HYPH	I-NP
O	894	900	active	active	JJ	I-NP
O	901	905	MEK1	MEK1	NN	I-NP
O	906	912	blocks	block	VBZ	B-VP
O	913	919	ephrin	ephrin	NN	B-NP
O	919	920	-	-	HYPH	I-NP
O	920	922	A5	A5	NN	I-NP
O	923	931	mediated	mediate	VBN	I-NP
B-Cellular_component	932	938	growth	growth	NN	I-NP
I-Cellular_component	939	943	cone	cone	NN	I-NP
O	944	952	collapse	collapse	NN	I-NP
O	952	953	.	.	.	O

O	954	958	Wild	Wild	JJ	B-NP
O	958	959	-	-	HYPH	I-NP
O	959	963	type	type	NN	I-NP
B-Cell	964	971	neurons	neuron	NNS	I-NP
O	972	976	were	be	VBD	B-VP
O	977	991	electroporated	electroporate	VBN	I-VP
O	992	996	with	with	IN	B-PP
O	997	1004	vectors	vector	NNS	B-NP
O	1005	1015	expressing	express	VBG	B-VP
O	1016	1019	GFP	GFP	NN	B-NP
O	1020	1021	(	(	(	O
O	1021	1028	control	control	NN	B-NP
O	1028	1029	;	;	:	O
O	1030	1031	A	A	DT	B-NP
O	1031	1032	,	,	,	O
O	1033	1034	C	C	NN	B-NP
O	1034	1035	,	,	,	O
O	1036	1037	E	E	NN	B-NP
O	1037	1038	)	)	)	O
O	1039	1041	or	or	CC	O
O	1042	1052	expressing	express	VBG	B-VP
O	1053	1054	a	a	DT	B-NP
O	1055	1059	FLAG	FLAG	NN	I-NP
O	1059	1060	-	-	HYPH	O
O	1060	1066	tagged	tag	VBN	B-VP
O	1067	1081	constitutively	constitutively	RB	B-ADVP
O	1081	1082	-	-	HYPH	B-NP
O	1082	1088	active	active	JJ	I-NP
O	1089	1093	MEK1	MEK1	NN	I-NP
O	1094	1095	(	(	(	O
O	1095	1097	CA	CA	NN	B-NP
O	1097	1098	-	-	HYPH	B-NP
O	1098	1102	MEK1	MEK1	NN	I-NP
O	1102	1103	;	;	:	O
O	1104	1105	B	B	NNP	B-NP
O	1105	1106	,	,	,	O
O	1107	1108	D	D	NNP	B-NP
O	1108	1109	,	,	,	O
O	1110	1111	F	F	NNP	B-NP
O	1111	1112	)	)	)	O
O	1112	1113	.	.	.	O

B-Cell	1114	1121	Neurons	Neuron	NNS	B-NP
O	1122	1126	were	be	VBD	B-VP
O	1127	1134	treated	treat	VBN	I-VP
O	1135	1139	with	with	IN	B-PP
O	1140	1146	ephrin	ephrin	NN	B-NP
O	1146	1147	-	-	HYPH	B-NP
O	1147	1149	A5	A5	NN	I-NP
O	1149	1150	-	-	HYPH	B-NP
O	1150	1152	Fc	Fc	NN	I-NP
O	1153	1156	for	for	IN	B-PP
O	1157	1159	30	30	CD	B-NP
O	1160	1163	min	min	NN	I-NP
O	1164	1172	followed	follow	VBN	B-VP
O	1173	1175	by	by	IN	B-PP
O	1176	1189	visualization	visualization	NN	B-NP
O	1190	1192	of	of	IN	B-PP
O	1193	1196	GFP	GFP	NN	B-NP
O	1197	1198	(	(	(	O
O	1198	1199	A	A	NN	B-NP
O	1199	1200	,	,	,	O
O	1201	1202	C	C	NN	B-NP
O	1202	1203	,	,	,	O
O	1204	1205	E	E	NN	B-NP
O	1205	1206	)	)	)	O
O	1207	1209	or	or	CC	O
O	1210	1212	CA	CA	NN	B-NP
O	1212	1213	-	-	HYPH	B-NP
O	1213	1216	MEK	MEK	NN	I-NP
O	1216	1217	-	-	HYPH	B-NP
O	1217	1218	1	1	CD	I-NP
O	1219	1220	(	(	(	O
O	1220	1225	green	green	NN	B-NP
O	1226	1228	in	in	IN	B-PP
O	1229	1230	B	B	NNP	B-NP
O	1230	1231	,	,	,	O
O	1232	1233	D	D	NNP	B-NP
O	1233	1234	,	,	,	O
O	1235	1236	F	F	NNP	B-NP
O	1236	1237	)	)	)	O
O	1237	1238	,	,	,	O
O	1239	1240	F	F	NN	B-NP
O	1240	1241	-	-	HYPH	B-NP
O	1241	1246	actin	actin	NN	I-NP
O	1247	1250	and	and	CC	I-NP
O	1251	1258	betaIII	betaIII	NN	I-NP
O	1259	1266	tubulin	tubulin	NN	I-NP
O	1266	1267	.	.	.	O

O	1268	1269	(	(	(	O
O	1269	1270	A	A	NN	B-NP
O	1270	1271	,	,	,	O
O	1272	1273	B	B	NN	B-NP
O	1273	1274	)	)	)	O
O	1275	1289	Overexpression	Overexpression	NN	B-NP
O	1290	1292	of	of	IN	B-PP
O	1293	1295	CA	CA	NN	B-NP
O	1295	1296	-	-	HYPH	O
O	1296	1300	MEK1	MEK1	NN	B-NP
O	1301	1302	(	(	(	O
O	1302	1303	B	B	NN	B-NP
O	1303	1304	)	)	)	O
O	1305	1312	reduces	reduce	VBZ	B-VP
O	1313	1317	mean	mean	JJ	B-NP
B-Cellular_component	1318	1325	neurite	neurite	NN	I-NP
O	1326	1332	length	length	NN	I-NP
O	1333	1341	compared	compare	VBN	B-VP
O	1342	1344	to	to	TO	B-PP
O	1345	1346	a	a	DT	B-NP
O	1347	1354	control	control	NN	I-NP
O	1355	1358	GFP	GFP	NN	I-NP
O	1358	1359	-	-	HYPH	O
O	1359	1369	expressing	express	VBG	B-VP
B-Cell	1370	1376	neuron	neuron	NN	B-NP
O	1377	1378	(	(	(	O
O	1378	1379	A	A	NN	B-NP
O	1379	1380	)	)	)	O
O	1380	1381	.	.	.	O

O	1382	1383	(	(	(	O
O	1383	1384	C	C	NN	B-NP
O	1384	1385	-	-	HYPH	B-NP
O	1385	1386	F	F	NN	I-NP
O	1386	1387	)	)	)	O
O	1388	1389	A	A	NN	B-NP
O	1390	1397	control	control	NN	I-NP
B-Cellular_component	1398	1404	growth	growth	NN	I-NP
I-Cellular_component	1405	1409	cone	cone	NN	I-NP
O	1410	1417	without	without	IN	B-PP
O	1418	1424	ephrin	ephrin	NN	B-NP
O	1424	1425	-	-	HYPH	O
O	1425	1427	A5	A5	NN	B-NP
O	1428	1439	application	application	NN	I-NP
O	1440	1441	(	(	(	O
O	1441	1442	C	C	NN	B-NP
O	1442	1443	)	)	)	O
O	1444	1453	typically	typically	RB	B-ADVP
O	1454	1463	protrudes	protrude	VBZ	B-VP
O	1464	1472	multiple	multiple	JJ	B-NP
B-Cellular_component	1473	1482	filopodia	filopodia	NN	I-NP
O	1483	1484	(	(	(	O
O	1484	1489	arrow	arrow	NN	B-NP
O	1489	1490	)	)	)	O
O	1490	1491	.	.	.	O

O	1492	1494	CA	CA	NN	B-NP
O	1494	1495	-	-	HYPH	I-NP
O	1495	1498	MEK	MEK	NN	I-NP
O	1498	1499	-	-	HYPH	B-NP
O	1499	1500	1	1	CD	I-NP
O	1501	1511	expressing	express	VBG	I-NP
B-Cellular_component	1512	1518	growth	growth	NN	I-NP
I-Cellular_component	1519	1524	cones	cone	NNS	I-NP
O	1525	1526	(	(	(	O
O	1526	1527	D	D	NN	B-NP
O	1527	1528	)	)	)	O
O	1529	1533	were	be	VBD	B-VP
O	1534	1551	indistinguishable	indistinguishable	JJ	B-ADJP
O	1552	1556	from	from	IN	B-PP
O	1557	1558	a	a	DT	B-NP
O	1559	1562	GFP	GFP	NN	I-NP
O	1562	1563	-	-	HYPH	O
O	1563	1573	expressing	express	VBG	B-VP
B-Cellular_component	1574	1580	growth	growth	NN	B-NP
I-Cellular_component	1581	1585	cone	cone	NN	I-NP
O	1585	1586	.	.	.	O

O	1587	1591	Note	Note	VB	B-VP
O	1592	1596	that	that	IN	B-SBAR
O	1597	1599	CA	CA	NN	B-NP
O	1599	1600	-	-	HYPH	B-NP
O	1600	1604	MEK1	MEK1	NN	I-NP
O	1605	1608	was	be	VBD	B-VP
O	1609	1618	expressed	express	VBN	I-VP
O	1619	1621	in	in	IN	B-PP
O	1622	1623	a	a	DT	B-NP
O	1624	1627	dot	dot	NN	I-NP
O	1627	1628	-	-	HYPH	B-NP
O	1628	1632	like	like	JJ	I-NP
O	1633	1640	pattern	pattern	NN	I-NP
O	1641	1643	in	in	IN	B-PP
O	1644	1647	the	the	DT	B-NP
B-Cellular_component	1648	1654	growth	growth	NN	I-NP
I-Cellular_component	1655	1659	cone	cone	NN	I-NP
O	1660	1661	(	(	(	O
O	1661	1671	arrowheads	arrowhead	NNS	B-NP
O	1672	1674	in	in	IN	B-PP
O	1675	1676	D	D	NN	B-NP
O	1677	1680	and	and	CC	O
O	1681	1682	F	F	NN	B-NP
O	1682	1683	)	)	)	O
O	1683	1684	.	.	.	O

O	1685	1689	Upon	Upon	IN	B-PP
O	1690	1696	ephrin	ephrin	NN	B-NP
O	1696	1697	-	-	HYPH	B-NP
O	1697	1699	A5	A5	NN	I-NP
O	1700	1711	application	application	NN	I-NP
O	1711	1712	,	,	,	O
O	1713	1714	a	a	DT	B-NP
O	1715	1722	control	control	NN	I-NP
B-Cellular_component	1723	1729	growth	growth	NN	I-NP
I-Cellular_component	1730	1734	cone	cone	NN	I-NP
O	1735	1736	(	(	(	O
O	1736	1737	E	E	NN	B-NP
O	1737	1738	)	)	)	O
O	1739	1748	collapsed	collapse	VBD	B-VP
O	1749	1758	resulting	result	VBG	I-VP
O	1759	1761	in	in	IN	B-PP
O	1762	1766	only	only	JJ	B-NP
O	1767	1770	few	few	JJ	I-NP
B-Cellular_component	1771	1780	filopodia	filopodia	NNS	I-NP
O	1780	1781	.	.	.	O

O	1782	1784	In	In	IN	B-PP
O	1785	1793	contrast	contrast	NN	B-NP
O	1793	1794	,	,	,	O
O	1795	1796	a	a	DT	B-NP
O	1797	1799	CA	CA	NN	I-NP
O	1799	1800	-	-	HYPH	O
O	1800	1804	MEK1	MEK1	NN	B-NP
O	1805	1815	expressing	express	VBG	B-VP
B-Cellular_component	1816	1822	growth	growth	NN	B-NP
I-Cellular_component	1823	1827	cone	cone	NN	I-NP
O	1828	1829	(	(	(	O
O	1829	1830	F	F	NN	B-NP
O	1830	1831	)	)	)	O
O	1832	1835	was	be	VBD	B-VP
O	1836	1840	only	only	RB	I-VP
O	1841	1850	partially	partially	RB	I-VP
O	1851	1860	collapsed	collapse	VBD	I-VP
O	1861	1864	and	and	CC	O
O	1865	1869	many	many	JJ	B-NP
B-Cellular_component	1870	1879	filopodia	filopodia	NN	I-NP
O	1880	1890	structures	structure	NNS	I-NP
O	1891	1895	were	be	VBD	B-VP
O	1896	1905	preserved	preserve	VBN	I-VP
O	1906	1911	after	after	IN	B-PP
O	1912	1918	ephrin	ephrin	NN	B-NP
O	1918	1919	-	-	HYPH	B-NP
O	1919	1921	A5	A5	NN	I-NP
O	1922	1931	induction	induction	NN	I-NP
O	1931	1932	.	.	.	O

O	1933	1934	(	(	(	O
O	1934	1935	G	G	NN	B-NP
O	1935	1936	)	)	)	O
O	1937	1951	Quantification	Quantification	NN	B-NP
O	1952	1954	of	of	IN	B-PP
O	1955	1962	average	average	JJ	B-NP
B-Cellular_component	1963	1970	neurite	neurite	NN	I-NP
O	1971	1977	length	length	NN	I-NP
O	1977	1978	.	.	.	O

O	1979	1980	(	(	(	O
O	1980	1981	H	H	NN	B-NP
O	1981	1982	,	,	,	I-NP
O	1983	1984	I	I	NN	I-NP
O	1984	1985	)	)	)	O
O	1986	2000	Quantification	Quantification	NN	B-NP
O	2001	2003	of	of	IN	B-PP
B-Cellular_component	2004	2010	growth	growth	NN	B-NP
I-Cellular_component	2011	2015	cone	cone	NN	I-NP
O	2016	2020	area	area	NN	I-NP
O	2021	2022	(	(	(	O
O	2022	2023	H	H	NN	B-NP
O	2023	2024	)	)	)	O
O	2025	2028	and	and	CC	O
B-Cellular_component	2029	2038	filopodia	filopodia	NN	B-NP
O	2039	2045	number	number	NN	I-NP
O	2045	2046	/	/	SYM	B-NP
B-Cellular_component	2046	2052	growth	growth	NN	I-NP
I-Cellular_component	2053	2057	cone	cone	NN	I-NP
O	2058	2059	(	(	(	O
O	2059	2060	I	I	NN	B-NP
O	2060	2061	)	)	)	O
O	2062	2064	in	in	IN	B-PP
O	2065	2068	the	the	DT	B-NP
O	2069	2073	four	four	CD	I-NP
O	2074	2084	conditions	condition	NNS	I-NP
O	2084	2085	.	.	.	O

O	2086	2092	Ephrin	Ephrin	NN	B-NP
O	2092	2093	-	-	HYPH	I-NP
O	2093	2095	A5	A5	NN	I-NP
O	2096	2103	induces	induce	VBZ	B-VP
O	2104	2105	a	a	DT	B-NP
B-Cellular_component	2106	2112	growth	growth	NN	I-NP
I-Cellular_component	2113	2117	cone	cone	NN	I-NP
O	2118	2126	collapse	collapse	NN	I-NP
O	2126	2127	,	,	,	O
O	2128	2137	resulting	result	VBG	B-VP
O	2138	2140	in	in	IN	B-PP
O	2141	2148	reduced	reduce	VBN	B-NP
B-Cellular_component	2149	2155	growth	growth	NN	I-NP
I-Cellular_component	2156	2160	cone	cone	NN	I-NP
O	2161	2165	area	area	NN	I-NP
O	2166	2169	and	and	CC	O
B-Cellular_component	2170	2179	filopodia	filopodia	NN	B-NP
O	2180	2186	number	number	NN	I-NP
O	2187	2189	in	in	IN	B-PP
O	2190	2193	GFP	GFP	NN	B-NP
O	2194	2197	but	but	CC	B-NP
O	2198	2201	not	not	RB	I-NP
O	2202	2204	CA	CA	NN	B-NP
O	2204	2205	-	-	HYPH	B-NP
O	2205	2209	MEK1	MEK1	NN	I-NP
O	2210	2220	expressing	express	VBG	B-VP
B-Cell	2221	2228	neurons	neuron	NNS	B-NP
O	2228	2229	.	.	.	O

O	2230	2235	Scale	Scale	JJ	B-NP
O	2235	2236	-	-	HYPH	I-NP
O	2236	2239	bar	bar	NN	I-NP
O	2240	2241	(	(	(	I-NP
O	2241	2242	A	A	NN	I-NP
O	2242	2243	,	,	,	I-NP
O	2244	2245	B	B	NN	I-NP
O	2245	2246	)	)	)	O
O	2247	2248	=	=	SYM	B-NP
O	2249	2251	10	10	CD	B-NP
O	2252	2258	microm	microm	NN	I-NP
O	2258	2259	;	;	:	O
O	2260	2261	(	(	(	O
O	2261	2262	C	C	NN	B-NP
O	2262	2263	-	-	HYPH	B-NP
O	2263	2264	F	F	NN	I-NP
O	2264	2265	)	)	)	O
O	2266	2267	=	=	SYM	B-VP
O	2268	2269	2	2	CD	B-NP
O	2270	2276	microm	microm	NN	I-NP
O	2276	2277	.	.	.	O

O	2278	2280	10	10	CD	B-NP
O	2280	2281	.	.	.	I-NP
O	2281	2285	1371	1371	CD	I-NP
O	2285	2286	/	/	SYM	I-NP
O	2286	2293	journal	journal	NN	I-NP
O	2293	2294	.	.	SYM	I-NP
O	2294	2298	pone	pone	NN	I-NP
O	2298	2299	.	.	.	O
O	2299	2306	0026089	0026089	CD	B-NP
O	2306	2307	.	.	.	O
O	2307	2311	g006	g006	CD	B-NP
O	2312	2318	Figure	Figure	NNP	I-NP
O	2319	2320	6	6	CD	I-NP

O	2321	2327	Ephrin	Ephrin	NN	B-NP
O	2327	2328	-	-	HYPH	I-NP
O	2328	2330	A5	A5	NN	I-NP
O	2331	2341	suppresses	suppress	VBZ	B-VP
O	2342	2346	BDNF	BDNF	NN	B-NP
O	2346	2347	-	-	HYPH	B-NP
O	2347	2354	induced	induce	VBN	I-NP
O	2355	2358	IEG	IEG	NN	I-NP
O	2359	2368	responses	response	NNS	I-NP
O	2369	2372	via	via	IN	B-PP
O	2373	2376	MAP	MAP	NN	B-NP
O	2377	2383	kinase	kinase	NN	I-NP
O	2384	2393	signaling	signaling	NN	I-NP
O	2393	2394	.	.	.	O

O	2395	2399	Wild	Wild	JJ	B-NP
O	2399	2400	-	-	HYPH	I-NP
O	2400	2404	type	type	NN	I-NP
B-Cell	2405	2413	cortical	cortical	JJ	I-NP
I-Cell	2414	2421	neurons	neuron	NNS	I-NP
O	2421	2422	,	,	,	O
O	2423	2427	mock	mock	NN	B-NP
O	2427	2428	-	-	HYPH	B-VP
O	2428	2442	electroporated	electroporate	VBN	I-VP
O	2443	2444	(	(	(	O
O	2444	2449	black	black	JJ	B-NP
O	2450	2454	bars	bar	NNS	I-NP
O	2454	2455	)	)	)	O
O	2456	2458	or	or	CC	O
O	2459	2463	with	with	IN	B-PP
O	2464	2465	a	a	DT	B-NP
O	2466	2472	vector	vector	NN	I-NP
O	2473	2483	expressing	express	VBG	B-VP
O	2484	2498	constitutively	constitutively	RB	B-ADVP
O	2498	2499	-	-	HYPH	B-NP
O	2499	2505	active	active	JJ	I-NP
O	2506	2510	MEK1	MEK1	NN	I-NP
O	2511	2512	(	(	(	O
O	2512	2517	white	white	JJ	B-NP
O	2518	2522	bars	bar	NNS	I-NP
O	2522	2523	)	)	)	O
O	2523	2524	,	,	,	O
O	2525	2529	were	be	VBD	B-VP
O	2530	2537	treated	treat	VBN	I-VP
O	2538	2542	with	with	IN	B-PP
O	2543	2551	guidance	guidance	NN	B-NP
O	2552	2556	cues	cue	NNS	I-NP
O	2557	2560	for	for	IN	B-PP
O	2561	2563	20	20	CD	B-NP
O	2564	2571	minutes	minute	NNS	I-NP
O	2572	2574	as	as	IN	B-SBAR
O	2575	2583	depicted	depict	VBN	B-VP
O	2583	2584	,	,	,	O
O	2585	2593	followed	follow	VBN	B-VP
O	2594	2596	by	by	IN	B-PP
O	2597	2601	mRNA	mRNA	NN	B-NP
O	2602	2616	quantification	quantification	NN	I-NP
O	2616	2617	.	.	.	O

O	2618	2620	In	In	IN	B-PP
O	2621	2625	mock	mock	NN	B-NP
O	2625	2626	-	-	HYPH	B-NP
O	2626	2640	electroporated	electroporate	VBN	I-NP
B-Cell	2641	2648	neurons	neuron	NNS	I-NP
O	2648	2649	,	,	,	O
O	2650	2654	BDNF	BDNF	NN	B-NP
O	2655	2662	induced	induce	VBD	B-VP
O	2663	2665	an	an	DT	B-NP
O	2666	2669	IEG	IEG	NN	I-NP
O	2670	2678	response	response	NN	I-NP
O	2679	2681	of	of	IN	B-PP
O	2682	2683	c	c	NN	B-NP
O	2683	2684	-	-	HYPH	O
O	2684	2687	fos	fos	NN	B-NP
O	2688	2689	(	(	(	O
O	2689	2690	A	A	NN	B-NP
O	2690	2691	)	)	)	O
O	2691	2692	,	,	,	O
O	2693	2697	Egr1	Egr1	NN	B-NP
O	2698	2699	(	(	(	O
O	2699	2700	B	B	NN	B-NP
O	2700	2701	)	)	)	O
O	2701	2702	,	,	,	O
O	2703	2707	Egr2	Egr2	NN	B-NP
O	2708	2709	(	(	(	O
O	2709	2710	C	C	NN	B-NP
O	2710	2711	)	)	)	O
O	2712	2715	and	and	CC	O
O	2716	2719	Arc	Arc	NN	B-NP
O	2720	2721	(	(	(	O
O	2721	2722	D	D	NN	B-NP
O	2722	2723	)	)	)	O
O	2723	2724	.	.	.	O

O	2725	2727	Co	Co	AFX	B-NP
O	2727	2728	-	-	HYPH	I-NP
O	2728	2739	application	application	NN	B-NP
O	2740	2742	of	of	IN	B-PP
O	2743	2749	ephrin	ephrin	NN	B-NP
O	2749	2750	-	-	HYPH	B-NP
O	2750	2752	A5	A5	NN	I-NP
O	2753	2756	and	and	CC	I-NP
O	2757	2761	BDNF	BDNF	NN	I-NP
O	2762	2769	reduced	reduce	VBD	B-VP
O	2770	2774	mRNA	mRNA	NN	B-NP
O	2775	2781	levels	level	NNS	I-NP
O	2782	2784	of	of	IN	B-PP
O	2785	2788	all	all	DT	B-NP
O	2789	2793	four	four	CD	I-NP
O	2794	2798	IEGs	IEG	NNS	I-NP
O	2799	2801	in	in	IN	B-PP
O	2802	2806	mock	mock	JJ	B-NP
O	2806	2807	-	-	HYPH	I-NP
O	2807	2821	electroporated	electroporate	VBN	I-NP
B-Cell	2822	2829	neurons	neuron	NNS	I-NP
O	2830	2831	(	(	(	O
O	2831	2832	A	A	NN	B-NP
O	2832	2833	-	-	HYPH	I-NP
O	2833	2834	D	D	NN	I-NP
O	2834	2835	)	)	)	O
O	2835	2836	.	.	.	O

O	2837	2839	In	In	IN	B-PP
O	2840	2848	contrast	contrast	NN	B-NP
O	2848	2849	,	,	,	O
O	2850	2860	expression	expression	NN	B-NP
O	2861	2863	of	of	IN	B-PP
O	2864	2878	constitutively	constitutively	RB	B-NP
O	2878	2879	-	-	HYPH	I-NP
O	2879	2885	active	active	JJ	I-NP
O	2886	2890	MEK1	MEK1	NN	I-NP
O	2891	2900	prevented	prevent	VBD	B-VP
O	2901	2904	Eph	Eph	NNP	B-NP
O	2905	2912	forward	forward	JJ	I-NP
O	2913	2922	signaling	signaling	NN	I-NP
O	2923	2927	from	from	IN	B-PP
O	2928	2939	suppressing	suppress	VBG	B-VP
O	2940	2944	BDNF	BDNF	NN	B-NP
O	2944	2945	-	-	HYPH	O
O	2945	2951	evoked	evoke	VBN	B-NP
O	2952	2955	IEG	IEG	NN	I-NP
O	2956	2965	responses	response	NNS	I-NP
O	2965	2966	.	.	.	O

O	2967	2971	This	This	DT	B-NP
O	2972	2975	was	be	VBD	B-VP
O	2976	2980	most	most	RBS	B-ADJP
O	2981	2988	evident	evident	JJ	I-ADJP
O	2989	2992	for	for	IN	B-PP
O	2993	2996	the	the	DT	B-NP
O	2997	3001	IEGs	IEG	NNS	I-NP
O	3002	3006	Egr1	Egr1	NN	I-NP
O	3007	3008	(	(	(	O
O	3008	3009	B	B	NN	B-NP
O	3009	3010	)	)	)	O
O	3011	3014	and	and	CC	O
O	3015	3019	Egr2	Egr2	NN	B-NP
O	3020	3021	(	(	(	O
O	3021	3022	C	C	NN	B-NP
O	3022	3023	)	)	)	O
O	3023	3024	.	.	.	O

O	3025	3030	First	First	RB	B-ADVP
O	3031	3033	of	of	IN	B-PP
O	3034	3037	all	all	DT	B-NP
O	3037	3038	,	,	,	O
O	3039	3041	we	we	PRP	B-NP
O	3042	3050	analyzed	analyze	VBD	B-VP
O	3051	3054	the	the	DT	B-NP
O	3055	3061	impact	impact	NN	I-NP
O	3062	3064	of	of	IN	B-PP
O	3065	3067	CA	CA	NN	B-NP
O	3067	3068	-	-	HYPH	B-NP
O	3068	3072	MEK1	MEK1	NN	I-NP
O	3073	3075	on	on	IN	B-PP
B-Cellular_component	3076	3083	neurite	neurite	NN	B-NP
O	3084	3093	outgrowth	outgrowth	NN	I-NP
O	3094	3097	and	and	CC	I-NP
O	3098	3104	ephrin	ephrin	NN	I-NP
O	3104	3105	-	-	HYPH	B-NP
O	3105	3107	A5	A5	NN	I-NP
O	3108	3116	mediated	mediate	VBN	I-NP
B-Cellular_component	3117	3123	growth	growth	NN	I-NP
I-Cellular_component	3124	3128	cone	cone	NN	I-NP
O	3129	3138	responses	response	NNS	I-NP
O	3139	3140	(	(	(	O
O	3140	3143	Fig	Fig	NNP	B-NP
O	3143	3144	.	.	.	I-NP
O	3145	3146	5	5	CD	I-NP
O	3146	3147	)	)	)	O
O	3147	3148	.	.	.	O

O	3149	3152	The	The	DT	B-NP
O	3153	3160	average	average	JJ	I-NP
B-Cellular_component	3161	3168	neurite	neurite	NN	I-NP
O	3169	3175	length	length	NN	I-NP
O	3176	3178	of	of	IN	B-PP
B-Cell	3179	3186	neurons	neuron	NNS	B-NP
O	3187	3201	overexpressing	overexpresse	VBG	B-VP
O	3202	3204	CA	CA	NN	B-NP
O	3204	3205	-	-	HYPH	B-NP
O	3205	3209	MEK1	MEK1	NN	I-NP
O	3210	3211	(	(	(	O
O	3211	3214	Fig	Fig	NNP	B-NP
O	3214	3215	.	.	.	I-NP
O	3216	3218	5B	5B	NN	I-NP
O	3218	3219	)	)	)	O
O	3220	3223	was	be	VBD	B-VP
O	3224	3231	clearly	clearly	RB	I-VP
O	3232	3239	reduced	reduce	VBN	I-VP
O	3240	3248	compared	compare	VBN	B-VP
O	3249	3251	to	to	TO	B-VP
O	3252	3259	control	control	VB	I-VP
O	3260	3263	GFP	GFP	NN	B-NP
O	3264	3274	expressing	express	VBG	B-VP
B-Cell	3275	3282	neurons	neuron	NNS	B-NP
O	3283	3284	(	(	(	O
O	3284	3287	Fig	Fig	NNP	B-NP
O	3287	3288	.	.	.	I-NP
O	3289	3291	5A	5A	NNP	I-NP
O	3291	3292	;	;	:	O
O	3293	3296	see	see	VB	B-VP
O	3297	3311	quantification	quantification	NN	B-NP
O	3312	3314	in	in	IN	B-PP
O	3315	3316	(	(	(	O
O	3316	3317	G	G	NN	B-NP
O	3317	3318	)	)	)	O
O	3318	3319	)	)	)	O
O	3319	3320	.	.	.	O

B-Cellular_component	3321	3327	Growth	Growth	NN	B-NP
I-Cellular_component	3328	3333	cones	cone	NNS	I-NP
O	3334	3336	of	of	IN	B-PP
O	3337	3340	GFP	GFP	NN	B-NP
O	3341	3342	(	(	(	O
O	3342	3343	C	C	NN	B-NP
O	3343	3344	)	)	)	O
O	3345	3348	and	and	CC	O
O	3349	3351	CA	CA	NN	B-NP
O	3351	3352	-	-	HYPH	B-NP
O	3352	3356	MEK1	MEK1	NN	I-NP
O	3357	3367	expressing	express	VBG	B-VP
B-Cell	3368	3375	neurons	neuron	NNS	B-NP
O	3376	3380	were	be	VBD	B-VP
O	3381	3388	similar	similar	JJ	B-ADJP
O	3389	3392	and	and	CC	O
O	3393	3402	protruded	protrude	VBD	B-VP
O	3403	3407	many	many	JJ	B-NP
B-Cellular_component	3408	3417	filopodia	filopodia	NN	I-NP
O	3418	3419	(	(	(	O
O	3419	3425	arrows	arrow	NNS	B-NP
O	3426	3428	in	in	IN	B-PP
O	3429	3432	Fig	Fig	NNP	B-NP
O	3432	3433	.	.	.	I-NP
O	3434	3436	5C	5C	NN	I-NP
O	3436	3437	-	-	HYPH	B-NP
O	3437	3438	F	F	NN	I-NP
O	3438	3439	)	)	)	O
O	3439	3440	.	.	.	O

O	3441	3443	CA	CA	NN	B-NP
O	3443	3444	-	-	HYPH	I-NP
O	3444	3448	MEK1	MEK1	NN	I-NP
O	3449	3459	expression	expression	NN	I-NP
O	3460	3462	in	in	IN	B-PP
B-Cellular_component	3463	3469	growth	growth	NN	B-NP
I-Cellular_component	3470	3475	cones	cone	NNS	I-NP
O	3476	3479	was	be	VBD	B-VP
O	3480	3488	confined	confine	VBN	I-VP
O	3489	3491	to	to	TO	B-PP
O	3492	3502	individual	individual	JJ	B-NP
O	3503	3506	dot	dot	NN	I-NP
O	3506	3507	-	-	HYPH	B-NP
O	3507	3511	like	like	JJ	I-NP
O	3512	3522	structures	structure	NNS	I-NP
O	3523	3524	(	(	(	O
O	3524	3534	arrowheads	arrowhead	NNS	B-NP
O	3535	3537	in	in	IN	B-PP
O	3538	3541	Fig	Fig	NNP	B-NP
O	3541	3542	.	.	.	I-NP
O	3543	3545	5D	5D	NN	I-NP
O	3545	3546	,	,	,	O
O	3547	3548	F	F	NN	B-NP
O	3548	3549	)	)	)	O
O	3549	3550	.	.	.	O

O	3551	3557	Ephrin	Ephrin	NN	B-NP
O	3557	3558	-	-	HYPH	I-NP
O	3558	3560	A5	A5	NN	I-NP
O	3561	3572	application	application	NN	I-NP
O	3573	3575	on	on	IN	B-PP
O	3576	3577	a	a	DT	B-NP
O	3578	3581	GFP	GFP	NN	I-NP
O	3582	3592	expressing	express	VBG	B-VP
O	3593	3600	control	control	NN	B-NP
B-Cellular_component	3601	3607	growth	growth	NN	I-NP
I-Cellular_component	3608	3612	cone	cone	NN	I-NP
O	3613	3614	(	(	(	O
O	3614	3617	Fig	Fig	NNP	B-NP
O	3617	3618	.	.	.	I-NP
O	3619	3621	5E	5E	NNP	I-NP
O	3621	3622	)	)	)	O
O	3623	3631	resulted	result	VBD	B-VP
O	3632	3634	in	in	IN	B-PP
O	3635	3636	a	a	DT	B-NP
B-Cellular_component	3637	3643	growth	growth	NN	I-NP
I-Cellular_component	3644	3648	cone	cone	NN	I-NP
O	3649	3657	collapse	collapse	NN	I-NP
O	3658	3660	as	as	IN	B-SBAR
O	3661	3669	revealed	reveal	VBN	B-VP
O	3670	3672	by	by	IN	B-PP
O	3673	3680	reduced	reduce	VBN	B-NP
O	3681	3688	overall	overall	JJ	I-NP
B-Cellular_component	3689	3695	growth	growth	NN	I-NP
I-Cellular_component	3696	3700	cone	cone	NN	I-NP
O	3701	3705	area	area	NN	I-NP
O	3706	3709	and	and	CC	O
B-Cellular_component	3710	3719	filopodia	filopodia	NN	B-NP
O	3720	3726	number	number	NN	I-NP
O	3727	3728	(	(	(	O
O	3728	3738	quantified	quantify	VBN	B-VP
O	3739	3741	in	in	IN	B-PP
O	3742	3745	Fig	Fig	NNP	B-NP
O	3745	3746	.	.	.	I-NP
O	3747	3749	5H	5H	NNP	I-NP
O	3749	3750	,	,	,	O
O	3751	3752	I	I	PRP	B-NP
O	3752	3753	)	)	)	O
O	3753	3754	.	.	.	O

O	3755	3757	In	In	IN	B-PP
O	3758	3766	contrast	contrast	NN	B-NP
O	3766	3767	,	,	,	O
O	3768	3770	in	in	IN	B-PP
B-Cell	3771	3778	neurons	neuron	NNS	B-NP
O	3779	3793	overexpressing	overexpresse	VBG	B-VP
O	3794	3796	CA	CA	NN	B-NP
O	3796	3797	-	-	HYPH	B-NP
O	3797	3801	MEK1	MEK1	NN	I-NP
O	3802	3803	(	(	(	O
O	3803	3806	Fig	Fig	NNP	B-NP
O	3806	3807	.	.	.	I-NP
O	3808	3810	5F	5F	NN	I-NP
O	3810	3811	)	)	)	O
O	3811	3812	,	,	,	O
O	3813	3819	ephrin	ephrin	NN	B-NP
O	3819	3820	-	-	HYPH	B-NP
O	3820	3822	A5	A5	NN	I-NP
O	3823	3830	induced	induce	VBD	B-VP
O	3831	3835	only	only	RB	B-NP
O	3836	3837	a	a	DT	I-NP
O	3838	3845	partial	partial	JJ	I-NP
B-Cellular_component	3846	3852	growth	growth	NN	I-NP
I-Cellular_component	3853	3857	cone	cone	NN	I-NP
O	3858	3866	collapse	collapse	NN	I-NP
O	3866	3867	.	.	.	O

O	3868	3872	Thus	Thus	RB	B-ADVP
O	3872	3873	,	,	,	O
B-Cellular_component	3874	3880	growth	growth	NN	B-NP
I-Cellular_component	3881	3885	cone	cone	NN	I-NP
O	3886	3890	area	area	NN	I-NP
O	3891	3894	and	and	CC	O
B-Cellular_component	3895	3904	filopodia	filopodia	NN	B-NP
O	3905	3911	number	number	NN	I-NP
O	3912	3916	were	be	VBD	B-VP
O	3917	3920	not	not	RB	I-VP
O	3921	3928	reduced	reduce	VBN	I-VP
O	3929	3930	(	(	(	O
O	3930	3933	see	see	VB	B-VP
O	3934	3937	Fig	Fig	NNP	B-NP
O	3937	3938	.	.	.	I-NP
O	3939	3941	5H	5H	NNP	I-NP
O	3941	3942	,	,	,	O
O	3943	3944	I	I	PRP	B-NP
O	3944	3945	)	)	)	O
O	3945	3946	.	.	.	O

O	3947	3951	This	This	DT	B-NP
O	3952	3958	result	result	NN	I-NP
O	3959	3967	suggests	suggest	VBZ	B-VP
O	3968	3972	that	that	IN	B-SBAR
O	3973	3975	an	an	DT	B-NP
O	3976	3982	ephrin	ephrin	NN	I-NP
O	3982	3983	-	-	HYPH	I-NP
O	3983	3985	A5	A5	NN	I-NP
O	3986	3993	induced	induce	VBN	I-NP
O	3994	4003	signaling	signaling	NN	I-NP
O	4004	4011	cascade	cascade	NN	I-NP
O	4012	4019	targets	target	VBZ	B-VP
O	4020	4023	MAP	MAP	NN	B-NP
O	4024	4030	kinase	kinase	NN	I-NP
O	4031	4040	signaling	signaling	NN	I-NP
O	4041	4043	to	to	TO	B-VP
O	4044	4049	exert	exert	VB	I-VP
O	4050	4051	a	a	DT	B-NP
O	4052	4056	full	full	JJ	I-NP
B-Cellular_component	4057	4063	growth	growth	NN	I-NP
I-Cellular_component	4064	4068	cone	cone	NN	I-NP
O	4069	4077	collapse	collapse	NN	I-NP
O	4077	4078	.	.	.	O

O	4079	4083	This	This	DT	B-NP
O	4084	4090	result	result	NN	I-NP
O	4091	4093	is	be	VBZ	B-VP
O	4094	4096	in	in	IN	B-PP
O	4097	4105	contrast	contrast	NN	B-NP
O	4106	4108	to	to	TO	B-PP
O	4109	4110	a	a	DT	B-NP
O	4111	4117	recent	recent	JJ	I-NP
O	4118	4124	report	report	NN	I-NP
O	4125	4126	[	[	(	O
O	4126	4128	46	46	CD	B-NP
O	4128	4129	]	]	)	O
O	4130	4135	which	which	WDT	B-NP
O	4136	4144	excluded	exclude	VBD	B-VP
O	4145	4148	ERK	ERK	NN	B-NP
O	4149	4158	signaling	signaling	NN	I-NP
O	4159	4169	downstream	downstream	JJ	B-ADJP
O	4170	4172	of	of	IN	B-PP
O	4173	4175	an	an	DT	B-NP
O	4176	4182	ephrin	ephrin	NN	I-NP
O	4182	4183	-	-	HYPH	I-NP
O	4183	4185	A5	A5	NN	I-NP
O	4186	4194	mediated	mediate	VBN	I-NP
B-Cellular_component	4195	4201	growth	growth	NN	I-NP
I-Cellular_component	4202	4206	cone	cone	NN	I-NP
O	4207	4215	collapse	collapse	NN	I-NP
O	4215	4216	.	.	.	O

O	4217	4221	Next	Next	RB	B-ADVP
O	4221	4222	,	,	,	O
O	4223	4225	we	we	PRP	B-NP
O	4226	4232	tested	test	VBD	B-VP
O	4233	4240	whether	whether	IN	B-SBAR
O	4241	4247	ephrin	ephrin	NN	B-NP
O	4247	4248	-	-	HYPH	B-NP
O	4248	4250	A5	A5	NN	I-NP
O	4251	4260	signaling	signaling	NN	I-NP
O	4261	4271	suppresses	suppress	VBZ	B-VP
O	4272	4275	ERK	ERK	NN	B-NP
O	4276	4282	kinase	kinase	NN	I-NP
O	4283	4292	signaling	signaling	NN	I-NP
O	4293	4297	also	also	RB	B-ADVP
O	4298	4300	to	to	TO	B-VP
O	4301	4310	interfere	interfere	VB	I-VP
O	4311	4315	with	with	IN	B-PP
O	4316	4320	BDNF	BDNF	NN	B-NP
O	4320	4321	-	-	HYPH	B-NP
O	4321	4329	mediated	mediate	VBN	I-NP
O	4330	4334	gene	gene	NN	I-NP
O	4335	4345	expression	expression	NN	I-NP
O	4346	4347	(	(	(	O
O	4347	4350	Fig	Fig	NNP	B-NP
O	4350	4351	.	.	.	I-NP
O	4352	4353	6	6	CD	I-NP
O	4353	4354	)	)	)	O
O	4354	4355	.	.	.	O

O	4356	4358	In	In	IN	B-PP
O	4359	4368	agreement	agreement	NN	I-PP
O	4369	4373	with	with	IN	I-PP
O	4374	4382	previous	previous	JJ	B-NP
O	4383	4390	results	result	NNS	I-NP
O	4391	4392	(	(	(	O
O	4392	4395	Fig	Fig	NNP	B-NP
O	4395	4396	.	.	.	I-NP
O	4397	4398	4	4	CD	I-NP
O	4398	4399	)	)	)	O
O	4399	4400	,	,	,	O
O	4401	4403	in	in	IN	B-PP
O	4404	4408	mock	mock	NN	B-NP
O	4408	4409	-	-	HYPH	B-NP
O	4409	4423	electroporated	electroporate	VBN	I-NP
B-Cell	4424	4431	neurons	neuron	NNS	I-NP
O	4431	4432	,	,	,	O
O	4433	4439	ephrin	ephrin	NN	B-NP
O	4439	4440	-	-	HYPH	I-NP
O	4440	4442	A5	A5	NN	I-NP
O	4443	4453	incubation	incubation	NN	I-NP
O	4454	4461	reduced	reduce	VBD	B-VP
O	4462	4465	the	the	DT	B-NP
O	4466	4470	BDNF	BDNF	NN	I-NP
O	4470	4471	-	-	HYPH	O
O	4471	4479	mediated	mediate	VBN	B-VP
O	4480	4482	up	up	RB	B-ADVP
O	4482	4483	-	-	HYPH	B-NP
O	4483	4493	regulation	regulation	NN	I-NP
O	4494	4496	of	of	IN	B-PP
O	4497	4498	c	c	NN	B-NP
O	4498	4499	-	-	HYPH	O
O	4499	4502	fos	fos	NN	B-NP
O	4503	4504	(	(	(	O
O	4504	4507	Fig	Fig	NNP	B-NP
O	4507	4508	.	.	.	I-NP
O	4509	4511	6A	6A	NNP	I-NP
O	4511	4512	)	)	)	O
O	4512	4513	,	,	,	O
O	4514	4518	Egr1	Egr1	NN	B-NP
O	4519	4520	(	(	(	O
O	4520	4523	Fig	Fig	NNP	B-NP
O	4523	4524	.	.	.	I-NP
O	4525	4527	6B	6B	NN	I-NP
O	4527	4528	)	)	)	O
O	4528	4529	,	,	,	O
O	4530	4534	Egr2	Egr2	NN	B-NP
O	4535	4536	(	(	(	O
O	4536	4539	Fig	Fig	NNP	B-NP
O	4539	4540	.	.	.	I-NP
O	4541	4543	6C	6C	NNP	I-NP
O	4543	4544	)	)	)	O
O	4545	4548	and	and	CC	O
O	4549	4552	Arc	Arc	NN	B-NP
O	4553	4554	(	(	(	O
O	4554	4557	Fig	Fig	NNP	B-NP
O	4557	4558	.	.	.	I-NP
O	4559	4561	6D	6D	NN	I-NP
O	4561	4562	)	)	)	O
O	4563	4567	mRNA	mRNA	NN	B-NP
O	4567	4568	.	.	.	O

O	4569	4571	In	In	IN	B-PP
O	4572	4580	contrast	contrast	NN	B-NP
O	4580	4581	,	,	,	O
O	4582	4584	in	in	IN	B-PP
B-Cell	4585	4592	neurons	neuron	NNS	B-NP
O	4593	4597	over	over	AFX	B-PP
O	4597	4598	-	-	HYPH	B-NP
O	4598	4608	expressing	express	VBG	B-VP
O	4609	4611	CA	CA	NN	B-NP
O	4611	4612	-	-	HYPH	B-NP
O	4612	4616	MEK1	MEK1	NN	I-NP
O	4616	4617	,	,	,	O
O	4618	4624	ephrin	ephrin	NN	B-NP
O	4624	4625	-	-	HYPH	B-NP
O	4625	4627	A5	A5	NN	I-NP
O	4628	4633	could	could	MD	B-VP
O	4634	4637	not	not	RB	I-VP
O	4638	4646	suppress	suppress	VB	I-VP
O	4647	4651	BDNF	BDNF	NN	B-NP
O	4651	4652	-	-	HYPH	B-NP
O	4652	4659	induced	induce	VBN	I-NP
O	4660	4663	IEG	IEG	NN	I-NP
O	4664	4673	responses	response	NNS	I-NP
O	4674	4676	to	to	TO	B-PP
O	4677	4680	the	the	DT	B-NP
O	4681	4685	same	same	JJ	I-NP
O	4686	4692	degree	degree	NN	I-NP
O	4692	4693	.	.	.	O

O	4694	4706	Particularly	Particularly	RB	B-NP
O	4707	4711	Egr1	Egr1	NN	I-NP
O	4712	4713	(	(	(	O
O	4713	4716	Fig	Fig	NNP	B-NP
O	4716	4717	.	.	.	I-NP
O	4718	4720	6B	6B	NN	I-NP
O	4720	4721	)	)	)	O
O	4722	4725	and	and	CC	O
O	4726	4730	Egr2	Egr2	NN	B-NP
O	4731	4732	(	(	(	O
O	4732	4735	Fig	Fig	NNP	B-NP
O	4735	4736	.	.	.	I-NP
O	4737	4739	6C	6C	NN	I-NP
O	4739	4740	)	)	)	O
O	4741	4745	mRNA	mRNA	NN	B-NP
O	4746	4752	levels	level	NNS	I-NP
O	4753	4757	were	be	VBD	B-VP
O	4758	4764	almost	almost	RB	B-ADJP
O	4765	4774	identical	identical	JJ	I-ADJP
O	4775	4779	when	when	WRB	B-ADVP
O	4780	4789	comparing	compare	VBG	B-VP
B-Cell	4790	4797	neurons	neuron	NNS	B-NP
O	4798	4805	treated	treat	VBN	B-VP
O	4806	4810	with	with	IN	B-PP
O	4811	4815	BDNF	BDNF	NN	B-NP
O	4816	4821	alone	alone	RB	B-ADVP
O	4822	4825	and	and	CC	O
B-Cell	4826	4833	neurons	neuron	NNS	B-NP
O	4834	4838	with	with	IN	B-PP
O	4839	4843	BDNF	BDNF	NN	B-NP
O	4844	4847	and	and	CC	I-NP
O	4848	4854	ephrin	ephrin	NN	I-NP
O	4854	4855	-	-	HYPH	B-NP
O	4855	4857	A5	A5	NN	I-NP
O	4858	4866	together	together	RB	B-ADVP
O	4866	4867	.	.	.	O

O	4868	4872	Thus	Thus	RB	B-ADVP
O	4872	4873	,	,	,	O
O	4874	4880	ephrin	ephrin	NN	B-NP
O	4880	4881	-	-	HYPH	O
O	4881	4883	A5	A5	NN	B-NP
O	4884	4893	represses	repress	VBZ	B-VP
O	4894	4898	gene	gene	NN	B-NP
O	4899	4907	activity	activity	NN	I-NP
O	4908	4916	elicited	elicit	VBN	B-VP
O	4917	4919	by	by	IN	B-PP
O	4920	4924	BDNF	BDNF	NN	B-NP
O	4925	4927	at	at	IN	B-ADVP
O	4928	4933	least	least	JJS	I-ADVP
O	4934	4936	in	in	IN	B-PP
O	4937	4941	part	part	NN	B-NP
O	4942	4945	via	via	IN	B-PP
O	4946	4949	MAP	MAP	NN	B-NP
O	4950	4957	kinases	kinase	NNS	I-NP
O	4957	4958	.	.	.	O

O	4959	4966	Besides	Besides	IN	B-PP
O	4967	4971	IEGs	IEG	NNS	B-NP
O	4971	4972	,	,	,	O
O	4973	4975	we	we	PRP	B-NP
O	4976	4985	inspected	inspect	VBD	B-VP
O	4986	4989	the	the	DT	B-NP
O	4990	4999	influence	influence	NN	I-NP
O	5000	5002	of	of	IN	B-PP
O	5003	5007	both	both	DT	B-NP
O	5008	5016	guidance	guidance	NN	I-NP
O	5017	5021	cues	cue	NNS	I-NP
O	5022	5024	on	on	IN	B-PP
B-Cellular_component	5025	5037	cytoskeletal	cytoskeletal	JJ	B-NP
O	5038	5043	genes	gene	NNS	I-NP
O	5043	5044	,	,	,	O
O	5045	5050	whose	whose	WP$	B-NP
O	5051	5055	gene	gene	NN	I-NP
O	5056	5064	products	product	NNS	I-NP
O	5065	5070	might	might	MD	B-VP
O	5071	5079	modulate	modulate	VB	I-VP
B-Cellular_component	5080	5092	cytoskeletal	cytoskeletal	JJ	B-NP
O	5093	5101	dynamics	dynamic	NNS	I-NP
O	5102	5108	evoked	evoke	VBN	B-VP
O	5109	5111	by	by	IN	B-PP
O	5112	5118	ephrin	ephrin	NN	B-NP
O	5118	5119	-	-	HYPH	B-ADJP
O	5119	5121	As	As	IN	B-SBAR
O	5122	5125	and	and	CC	O
O	5125	5126	/	/	SYM	B-NP
O	5126	5128	or	or	CC	O
O	5129	5142	neurotrophins	neurotrophin	NNS	B-NP
O	5143	5144	(	(	(	O
O	5144	5147	Fig	Fig	NNP	B-NP
O	5147	5148	.	.	.	I-NP
O	5149	5151	S4	S4	NN	I-NP
O	5151	5152	)	)	)	O
O	5152	5153	.	.	.	O

O	5154	5163	Therefore	Therefore	RB	B-ADVP
O	5163	5164	,	,	,	O
O	5165	5168	the	the	DT	B-NP
B-Cellular_component	5169	5180	filamentous	filamentous	JJ	I-NP
O	5181	5186	actin	actin	NN	I-NP
O	5187	5188	(	(	(	O
O	5188	5189	F	F	NN	B-NP
O	5189	5190	-	-	HYPH	B-NP
O	5190	5195	actin	actin	NN	I-NP
O	5195	5196	)	)	)	O
O	5197	5208	stabilizing	stabilize	VBG	B-VP
O	5209	5221	tropomyosins	tropomyosin	NNS	B-NP
O	5222	5223	(	(	(	O
O	5223	5227	Tpm1	Tpm1	NN	B-NP
O	5228	5231	and	and	CC	O
O	5232	5236	Tpm2	Tpm2	NN	B-NP
O	5236	5237	)	)	)	O
O	5237	5238	,	,	,	O
O	5239	5242	the	the	DT	B-NP
O	5243	5244	F	F	NN	I-NP
O	5244	5245	-	-	HYPH	B-NP
O	5245	5250	actin	actin	NN	I-NP
O	5251	5256	cross	cross	AFX	O
O	5256	5257	-	-	HYPH	B-NP
O	5257	5263	linker	linker	NN	I-NP
O	5264	5269	alpha	alpha	SYM	I-NP
O	5269	5270	-	-	HYPH	I-NP
O	5270	5277	actinin	actinin	NN	B-NP
O	5278	5279	1	1	CD	I-NP
O	5280	5281	(	(	(	O
O	5281	5286	Actn1	Actn1	NN	B-NP
O	5286	5287	)	)	)	O
O	5288	5291	and	and	CC	O
O	5292	5295	the	the	DT	B-NP
O	5296	5301	motor	motor	NN	I-NP
O	5302	5309	protein	protein	NN	I-NP
O	5310	5316	dynein	dynein	NN	I-NP
O	5317	5322	light	light	JJ	I-NP
O	5323	5328	chain	chain	NN	I-NP
O	5329	5330	1	1	CD	I-NP
O	5331	5332	(	(	(	O
O	5332	5337	Dnal1	Dnal1	NN	B-NP
O	5337	5338	)	)	)	O
O	5339	5343	were	be	VBD	B-VP
O	5344	5352	analyzed	analyze	VBN	I-VP
O	5352	5353	.	.	.	O

O	5354	5358	mRNA	mRNA	NN	B-NP
O	5359	5365	levels	level	NNS	I-NP
O	5366	5368	of	of	IN	B-PP
O	5369	5374	other	other	JJ	B-NP
B-Cellular_component	5375	5387	cytoskeletal	cytoskeletal	JJ	I-NP
O	5388	5393	genes	gene	NNS	I-NP
O	5394	5398	were	be	VBD	B-VP
O	5399	5402	not	not	RB	I-VP
O	5403	5410	altered	alter	VBN	I-VP
O	5411	5413	by	by	IN	B-PP
O	5414	5417	any	any	DT	B-NP
O	5418	5420	of	of	IN	B-PP
O	5421	5424	the	the	DT	B-NP
O	5425	5433	guidance	guidance	NN	I-NP
O	5434	5438	cues	cue	NNS	I-NP
O	5439	5440	(	(	(	O
O	5440	5441	i	i	NN	B-NP
O	5441	5442	.	.	.	O
O	5442	5443	e	e	NN	B-NP
O	5443	5444	.	.	.	O
O	5445	5452	cofilin	cofilin	NN	B-NP
O	5452	5453	,	,	,	O
O	5454	5461	filamin	filamin	NN	B-NP
O	5462	5463	A	A	NN	I-NP
O	5463	5464	,	,	,	O
O	5465	5469	mena	mena	NN	B-NP
O	5469	5470	,	,	,	O
O	5471	5479	vinculin	vinculin	NN	B-NP
O	5480	5483	and	and	CC	O
B-Tissue	5484	5490	smooth	smooth	JJ	B-NP
I-Tissue	5491	5497	muscle	muscle	NN	I-NP
O	5498	5503	actin	actin	NN	I-NP
O	5503	5504	;	;	:	O
O	5505	5509	data	datum	NNS	B-NP
O	5510	5513	not	not	RB	B-VP
O	5514	5519	shown	show	VBN	I-VP
O	5519	5520	)	)	)	O
O	5520	5521	.	.	.	O

O	5522	5527	Short	Short	JJ	B-NP
O	5527	5528	-	-	HYPH	I-NP
O	5528	5532	term	term	NN	I-NP
O	5533	5544	stimulation	stimulation	NN	I-NP
O	5545	5549	with	with	IN	B-PP
O	5550	5558	guidance	guidance	NN	B-NP
O	5559	5563	cues	cue	NNS	I-NP
O	5564	5567	did	do	VBD	B-VP
O	5568	5571	not	not	RB	I-VP
O	5572	5578	result	result	VB	I-VP
O	5579	5581	in	in	IN	B-PP
O	5582	5587	major	major	JJ	B-NP
O	5588	5599	alterations	alteration	NNS	I-NP
O	5600	5602	of	of	IN	B-PP
B-Cellular_component	5603	5615	cytoskeletal	cytoskeletal	JJ	B-NP
O	5616	5620	mRNA	mRNA	NN	I-NP
O	5621	5627	levels	level	NNS	I-NP
O	5628	5634	except	except	IN	B-PP
O	5635	5638	for	for	IN	B-PP
O	5639	5651	upregulation	upregulation	NN	B-NP
O	5652	5654	of	of	IN	B-PP
O	5655	5659	Tpm1	Tpm1	NN	B-NP
O	5660	5662	by	by	IN	B-PP
O	5663	5669	ephrin	ephrin	NN	B-NP
O	5669	5670	-	-	HYPH	B-NP
O	5670	5672	A5	A5	NN	I-NP
O	5673	5674	(	(	(	O
O	5674	5677	Fig	Fig	NNP	B-NP
O	5677	5678	.	.	.	I-NP
O	5679	5682	S4A	S4A	NN	I-NP
O	5682	5683	)	)	)	O
O	5683	5684	.	.	.	O

O	5685	5687	At	At	IN	B-PP
O	5688	5691	16h	16h	NN	B-NP
O	5692	5694	of	of	IN	B-PP
O	5695	5705	incubation	incubation	NN	B-NP
O	5705	5706	,	,	,	O
O	5707	5711	both	both	DT	B-NP
O	5712	5723	tropomyosin	tropomyosin	NN	I-NP
O	5724	5729	genes	gene	NNS	I-NP
O	5730	5734	were	be	VBD	B-VP
O	5735	5742	induced	induce	VBN	I-VP
O	5743	5745	by	by	IN	B-PP
O	5746	5750	BDNF	BDNF	NN	B-NP
O	5751	5754	and	and	CC	I-NP
O	5755	5761	ephrin	ephrin	NN	I-NP
O	5761	5762	-	-	HYPH	I-NP
O	5762	5764	A5	A5	NN	I-NP
O	5765	5770	alone	alone	RB	B-ADVP
O	5771	5774	and	and	CC	O
O	5775	5779	both	both	DT	B-NP
O	5780	5788	together	together	RB	B-ADVP
O	5789	5790	(	(	(	O
O	5790	5793	Fig	Fig	NNP	B-NP
O	5793	5794	.	.	.	I-NP
O	5795	5798	S4B	S4B	NN	I-NP
O	5798	5799	,	,	,	O
O	5800	5801	D	D	NN	B-NP
O	5801	5802	)	)	)	O
O	5802	5803	.	.	.	O

O	5804	5809	Actn1	Actn1	NN	B-NP
O	5810	5816	levels	level	NNS	I-NP
O	5817	5821	were	be	VBD	B-VP
O	5822	5829	induced	induce	VBN	I-VP
O	5830	5832	by	by	IN	B-PP
O	5833	5843	individual	individual	JJ	B-NP
O	5844	5855	application	application	NN	I-NP
O	5856	5858	of	of	IN	B-PP
O	5859	5865	ephrin	ephrin	NN	B-NP
O	5865	5866	-	-	HYPH	B-NP
O	5866	5868	A5	A5	NN	I-NP
O	5869	5872	and	and	CC	I-NP
O	5873	5877	BDNF	BDNF	NN	I-NP
O	5878	5881	and	and	CC	B-PP
O	5882	5884	by	by	IN	B-PP
O	5885	5887	co	co	AFX	B-NP
O	5887	5888	-	-	HYPH	I-NP
O	5888	5899	application	application	NN	B-NP
O	5900	5902	of	of	IN	B-PP
O	5903	5907	both	both	DT	B-NP
O	5908	5909	(	(	(	I-NP
O	5909	5912	Fig	Fig	NNP	I-NP
O	5912	5913	.	.	.	I-NP
O	5914	5917	S4F	S4F	NN	I-NP
O	5917	5918	)	)	)	O
O	5918	5919	.	.	.	O

O	5920	5921	A	A	DT	B-NP
O	5922	5929	similar	similar	JJ	I-NP
O	5930	5937	profile	profile	NN	I-NP
O	5938	5941	was	be	VBD	B-VP
O	5942	5950	observed	observe	VBN	I-VP
O	5951	5954	for	for	IN	B-PP
O	5955	5958	the	the	DT	B-NP
O	5959	5965	dynein	dynein	NN	I-NP
O	5966	5971	light	light	JJ	I-NP
O	5972	5977	chain	chain	NN	I-NP
O	5978	5979	(	(	(	O
O	5979	5982	Fig	Fig	NNP	B-NP
O	5982	5983	.	.	.	I-NP
O	5984	5987	S4H	S4H	NN	I-NP
O	5987	5988	)	)	)	O
O	5988	5989	.	.	.	O

O	5990	5995	Taken	Take	VBN	B-VP
O	5996	6004	together	together	RB	B-ADVP
O	6004	6005	,	,	,	O
B-Cellular_component	6006	6018	cytoskeletal	cytoskeletal	JJ	B-NP
O	6019	6023	gene	gene	NN	I-NP
O	6024	6034	expression	expression	NN	I-NP
O	6035	6038	was	be	VBD	B-VP
O	6039	6048	modulated	modulate	VBN	I-VP
O	6049	6051	by	by	IN	B-PP
O	6052	6058	ephrin	ephrin	NN	B-NP
O	6058	6059	-	-	HYPH	B-NP
O	6059	6061	A5	A5	NN	I-NP
O	6062	6065	and	and	CC	I-NP
O	6066	6070	BDNF	BDNF	NN	I-NP
O	6070	6071	.	.	.	O

O	6072	6074	In	In	IN	B-PP
O	6075	6083	contrast	contrast	NN	B-NP
O	6084	6086	to	to	TO	B-PP
O	6087	6090	the	the	DT	B-NP
O	6091	6103	antagonistic	antagonistic	JJ	I-NP
O	6104	6110	impact	impact	NN	I-NP
O	6111	6113	on	on	IN	B-PP
O	6114	6117	the	the	DT	B-NP
O	6118	6121	IEG	IEG	NN	I-NP
O	6122	6126	gene	gene	NN	I-NP
O	6127	6135	response	response	NN	I-NP
O	6136	6137	(	(	(	O
O	6137	6141	Figs	Fig	NNS	B-NP
O	6141	6142	.	.	.	O
O	6143	6144	4	4	CD	B-NP
O	6145	6148	and	and	CC	I-NP
O	6149	6150	6	6	CD	I-NP
O	6150	6151	)	)	)	O
O	6151	6152	,	,	,	O
O	6153	6159	ephrin	ephrin	NN	B-NP
O	6159	6160	-	-	HYPH	B-NP
O	6160	6162	A5	A5	NN	I-NP
O	6163	6166	and	and	CC	I-NP
O	6167	6171	BDNF	BDNF	NN	I-NP
O	6172	6180	resulted	result	VBD	B-VP
O	6181	6183	in	in	IN	B-PP
O	6184	6190	rather	rather	RB	B-NP
O	6191	6202	synergistic	synergistic	JJ	I-NP
O	6203	6209	action	action	NN	I-NP
O	6210	6212	on	on	IN	B-PP
B-Cellular_component	6213	6225	cytoskeletal	cytoskeletal	JJ	B-NP
O	6226	6230	gene	gene	NN	I-NP
O	6231	6241	expression	expression	NN	I-NP
O	6241	6242	.	.	.	O

O	6243	6247	This	This	DT	B-NP
O	6248	6258	difference	difference	NN	I-NP
O	6259	6264	might	might	MD	B-VP
O	6265	6267	be	be	VB	I-VP
O	6268	6271	due	due	JJ	B-ADVP
O	6272	6274	to	to	TO	B-PP
O	6275	6280	short	short	JJ	B-NP
O	6280	6281	-	-	HYPH	I-NP
O	6281	6285	term	term	NN	I-NP
O	6286	6287	(	(	(	O
O	6287	6288	i	i	NN	B-NP
O	6288	6289	.	.	.	O
O	6289	6290	e	e	NN	B-NP
O	6290	6291	.	.	.	O
O	6292	6294	20	20	CD	B-NP
O	6295	6302	minutes	minute	NNS	I-NP
O	6302	6303	)	)	)	O
O	6304	6306	vs	v	NNS	B-NP
O	6306	6307	.	.	.	O
O	6308	6312	long	long	JJ	B-NP
O	6312	6313	-	-	HYPH	I-NP
O	6313	6317	term	term	NN	I-NP
O	6318	6319	(	(	(	O
O	6319	6320	i	i	NN	B-NP
O	6320	6321	.	.	.	O
O	6321	6322	e	e	NN	B-NP
O	6322	6323	.	.	.	O
O	6324	6327	16h	16h	CD	O
O	6327	6328	)	)	)	O
O	6329	6337	exposure	exposure	NN	B-NP
O	6338	6340	of	of	IN	B-PP
O	6341	6345	both	both	DT	B-NP
O	6346	6354	guidance	guidance	NN	I-NP
O	6355	6359	cues	cue	NNS	I-NP
O	6360	6362	in	in	IN	B-PP
O	6363	6366	the	the	DT	B-NP
O	6367	6370	IEG	IEG	NN	I-NP
O	6371	6374	and	and	CC	I-NP
B-Cellular_component	6375	6387	cytoskeletal	cytoskeletal	JJ	I-NP
O	6388	6392	gene	gene	NN	I-NP
O	6393	6401	response	response	NN	I-NP
O	6401	6402	,	,	,	O
O	6403	6415	respectively	respectively	RB	B-ADVP
O	6415	6416	.	.	.	O

